Imc Chicago, LLC Bristol Myers Squibb CO Transaction History

Imc Chicago, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$65.71 - $74.53 $443,739 - $503,301	-6,753 Reduced 31.83%	14,464 $1 Million
Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $1.45 Million - $1.72 Million	21,217 New	21,217 $1.53 Million
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $784,647 - $854,481	12,674 New	12,674 $847,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $2.19 Million - $2.47 Million	-36,970 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$57.74 - $65.43 $2.13 Million - $2.42 Million	36,970 New	36,970 $2.29 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $11.4 Million - $16.6 Million	-245,836 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $12.1 Million - $15.8 Million	245,836 New	245,836 $15.8 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $738,509 - $875,609	-17,267 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$44.62 - $49.34 $770,453 - $851,953	17,267 New	17,267 $783,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

Stay updated on Imc Chicago, LLC with notifications on news.